Previous data-driven investigations of optimal tau PET biomarkers for Alzheimer’s disease are mostly SUVR-based (note that the Centiloid7/CenTauR8 scales depend on SUVR). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.